SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-141398
Filing Date
2022-05-05
Accepted
2022-05-05 08:19:02
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A d300424ddefa14a.htm DEFA14A 23864
2 GRAPHIC g300424g0505051442900.jpg GRAPHIC 3403
  Complete submission text file 0001193125-22-141398.txt   29774
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39503 | Film No.: 22894208
SIC: 2836 Biological Products, (No Diagnostic Substances)